The angiotensin type 2 receptor agonist C21 restores respiratory function in COVID19 - a double-blind, randomized, placebo-controlled Phase 2 trial

Tornling G, Batta R, Porter J, Bengtsson T, Parmar K, Kashiva R, Cohrt AK, Westergaard K, Hallberg A, Dalsgaard CJ, Raud J

medRxiv - (-) - [2021-01-28; online 2021-01-28]

Category: Biochemistry

Category: Drug Discovery

Type: Preprint

DOI 10.1101/2021.01.26.21250511

Crossref 10.1101/2021.01.26.21250511


Publications 7.1.2